thiazoles has been researched along with Long QT Syndrome in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 24 (50.00) | 29.6817 |
2010's | 22 (45.83) | 24.3611 |
2020's | 2 (4.17) | 2.80 |
Authors | Studies |
---|---|
Ataei, F; Dou, Y; Eldstrom, J; Fedida, D; Kyriakis, E; Russo, S; Sahakyan, H; Van Petegem, F; Willegems, K | 1 |
Chiba, K; Goto, A; Hagiwara-Nagasawa, M; Izumi-Nakaseko, H; Kambayashi, R; Matsumoto, A; Naito, AT; Sugiyama, A | 1 |
Cui, J; Gao, Y; Hou, P; Shi, J; White, KM | 1 |
Erbas, O; Yilmaz, M | 1 |
Achtyes, ED; Buckley, P; Bustillo, JR; Citrome, L; Gil, R; Goff, DC; Macklin, EA; Manschreck, TC; McEvoy, JP; Mech, AW | 1 |
Hnatkova, K; Keirns, JJ; Kowalski, D; Malik, M; Van Gelderen, EM | 1 |
Brossard, P; Darpo, B; Dingemanse, J; Hoch, M; Stoltz, R; Zhou, M | 1 |
Aalto-Setälä, K; Kim, J; Kuusela, J; Räsänen, E | 1 |
Hamilton, JB; Heaton, C; Lannan, R; Lavedan, C; Licamele, L; Mack, K; Polymeropoulos, MH; Volpi, S; Wolfgang, CD | 1 |
Dressing, H; Krumm, B; Kuwilsky, A; Zink, M | 1 |
Lin, YL; Tsai, GF; Wu, YC | 1 |
Alipour, A; Cruz, R; Lott, RS | 1 |
Strawn, JR; Tambyraja, R | 1 |
D'Agostino, RB; Eng, SM; Faich, G; Kane, JM; Reynolds, RF; Ruskin, J; Strom, BL | 1 |
Stroup, TS | 1 |
Citrome, L | 1 |
Correll, CU; Figen, V; Kane, JM; Lops, JD; Malhotra, AK; Manu, P | 1 |
Nielsen, J | 1 |
Mycyk, MB; Witsil, JC; Zell-Kanter, M | 1 |
Hasnain, M; Vieweg, WV | 1 |
Kane, JM | 1 |
Sanaei-Zadeh, H | 1 |
Fukui, N; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
Camm, AJ; Kane, JM; Karayal, ON; Kolluri, S; Meltzer, H; Miceli, J; O'Gorman, C; Tensfeldt, T | 1 |
Mencacci, C | 1 |
de Koning, P; Goldwater, R; Kaibara, A; Keirns, JJ; Kowalski, DL; Lee, JH; Malik, M; Moy, SS; Mujais, SK; Schaddelee, MP; van Gelderen, EM; Yen, M | 1 |
Hochfeld, M; Meng, X; Potkin, SG; Preskorn, S | 1 |
Kelly, DL; Love, RC | 1 |
Biswas, AK; Mayes, KL; Morris-Kukoski, CL; Zabrocki, LA | 2 |
Taylor, D | 1 |
Teich, J | 1 |
Jaffe, R; Leavitt, R; Wind, T | 1 |
Martel, ML | 1 |
Levy, WO; Nunez, C; Robichaux-Keene, NR | 1 |
Minov, C | 1 |
Finzel, M; Fric, M; Laux, G | 1 |
Baldessarini, RJ; Berry, JM; Centorrino, F; Fogarty, KV; Kidwell, JE; MacLean, E; Salvatore, P | 1 |
Blair, J; Martin, A; Scahill, L; State, M | 1 |
Brown, FW; Greco, KE; Tune, LE; Van Horn, WA | 1 |
Chappell, P; Loebel, A; Miceli, J; Siu, C | 1 |
Scott, LJ; Swainston Harrison, T | 1 |
Hoffman, RS; Manini, AF; Nelson, LS; Raspberry, D | 1 |
D'Agostino, RB; Eng, SM; Faich, GA; Kane, JM; Reynolds, RF; Ruskin, JN; Strom, BL | 1 |
Bentley, ML; Biscardi, FH; Butcher, C; Levitov, A | 1 |
Caley, CF; Cooper, CK | 1 |
Crismon, L; Dorson, PG; Patel, NC; Sierk, P | 1 |
Taylor, DM | 1 |
7 review(s) available for thiazoles and Long QT Syndrome
Article | Year |
---|---|
Drug safety evaluation of ziprasidone.
Topics: Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Humans; Long QT Syndrome; Piperazines; Schizophrenia; Thiazoles | 2011 |
Lurasidone: a clinical overview.
Topics: Antipsychotic Agents; Blood Glucose; Body Weight; Humans; Hypotension, Orthostatic; Isoindoles; Long QT Syndrome; Lurasidone Hydrochloride; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bipolar Disorder; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Dose-Response Relationship, Drug; Electrocardiography; Humans; Long QT Syndrome; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles | 2012 |
Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
Topics: Animals; Antipsychotic Agents; Electrocardiography; Humans; Long QT Syndrome; Piperazines; Thiazoles | 2001 |
Ziprasidone in the management of schizophrenia : the QT interval issue in context.
Topics: Antipsychotic Agents; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Risk Assessment; Risk Factors; Schizophrenia; Sex Factors; Thiazoles; Torsades de Pointes | 2003 |
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
Topics: Antipsychotic Agents; Area Under Curve; Humans; Injections, Intramuscular; Long QT Syndrome; Piperazines; Psychotic Disorders; Schizophrenia; Tablets; Thiazoles; Treatment Outcome | 2006 |
Ziprasidone: the fifth atypical antipsychotic.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Headache; Humans; Injections, Intramuscular; Long QT Syndrome; Nausea; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
11 trial(s) available for thiazoles and Long QT Syndrome
Article | Year |
---|---|
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study.
Topics: Adult; Antipsychotic Agents; Blood Pressure; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; United States | 2013 |
Effect of ponesimod, a selective S1P1 receptor modulator, on the QT interval in healthy individuals.
Topics: Action Potentials; Adolescent; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Receptors, Lysosphingolipid; Risk Assessment; Sphingosine-1-Phosphate Receptors; Thiazoles; Time Factors; Young Adult | 2015 |
Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Carrier Proteins; CELF Proteins; Cytoskeletal Proteins; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Gene Frequency; Genome-Wide Association Study; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Isoxazoles; Linear Models; Linkage Disequilibrium; Long QT Syndrome; Male; Middle Aged; Neuregulins; Organic Anion Transporters; Pharmacogenetics; Phosphoproteins; Phosphotransferases (Alcohol Group Acceptor); Piperazines; Piperidines; Polymorphism, Single Nucleotide; RNA-Binding Proteins; Schizophrenia; Thiazoles; Young Adult | 2009 |
Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cause of Death; Cross-Sectional Studies; Death, Sudden, Cardiac; Diabetic Ketoacidosis; Female; Hospitalization; Humans; Incidence; Kaplan-Meier Estimate; Long QT Syndrome; Male; Middle Aged; Myocardial Infarction; Olanzapine; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Risk; Schizophrenia; Suicide; Thiazoles | 2011 |
Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial.
Topics: Adult; Antipsychotic Agents; Female; Humans; Long QT Syndrome; Male; Middle Aged; Patient Preference; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles | 2012 |
Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study.
Topics: Acetanilides; Adolescent; Adrenergic beta-Agonists; Adult; Anti-Infective Agents; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Sex Characteristics; Thiazoles; Urinary Bladder, Overactive; Young Adult | 2012 |
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dibenzothiazepines; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Electrocardiography; Enzyme Inhibitors; Female; Genotype; Heart Rate; Humans; Isoxazoles; Ketoconazole; Linear Models; Long QT Syndrome; Male; Middle Aged; Paroxetine; Pharmacogenetics; Phenotype; Piperazines; Piperidines; Quetiapine Fumarate; Thiazoles; United States; Young Adult | 2013 |
[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
Topics: Antipsychotic Agents; Electrocardiography; Germany; Hospitalization; Hospitals, Psychiatric; Humans; Long QT Syndrome; Piperazines; Prospective Studies; Psychotic Disorders; Risk Assessment; Thiazoles; Torsades de Pointes | 2004 |
Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study.
Topics: Adolescent; Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Obsessive-Compulsive Disorder; Piperazines; Prospective Studies; Psychotic Disorders; Thiazoles; Tourette Syndrome | 2005 |
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Hypertension; Long QT Syndrome; Male; Observation; Piperazines; Prevalence; Research Design; Schizophrenia; Severity of Illness Index; Surveys and Questionnaires; Thiazoles; Triglycerides | 2008 |
30 other study(ies) available for thiazoles and Long QT Syndrome
Article | Year |
---|---|
Structural and electrophysiological basis for the modulation of KCNQ1 channel currents by ML277.
Topics: Animals; KCNQ1 Potassium Channel; Long QT Syndrome; Mutation; Piperidines; Thiazoles; Tosyl Compounds; Xenopus | 2022 |
Experimental analysis of the onset mechanism of TdP reported in an LQT3 patient during pharmacological treatment with serotonin-dopamine antagonists against insomnia and nocturnal delirium.
Topics: Action Potentials; Anesthetics, Inhalation; Animals; Calcium Channel Agonists; Cardiac Conduction System Disease; Delirium; Dogs; Dopamine Antagonists; Dose-Response Relationship, Drug; Electrocardiography; Female; Halothane; Heart Conduction System; Humans; Isoindoles; Long QT Syndrome; Middle Aged; Models, Animal; Piperazines; Piperidines; Potassium Channel Blockers; Serotonin Antagonists; Sleep Initiation and Maintenance Disorders; Thiazoles; Torsades de Pointes | 2020 |
ML277 specifically enhances the fully activated open state of KCNQ1 by modulating VSD-pore coupling.
Topics: Animals; Cell Membrane; Cell Polarity; Humans; KCNQ1 Potassium Channel; Long QT Syndrome; Oocytes; Piperidines; Potassium; Potassium Channels, Voltage-Gated; Thiazoles; Tosyl Compounds; Xenopus | 2019 |
Metoprolol and diltiazem ameliorate ziprasidone-induced prolonged corrected QT interval in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Anesthesia; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Calcium Channel Blockers; Diltiazem; Electrocardiography; Heart; Injections, Intraperitoneal; Long QT Syndrome; Male; Metoprolol; Piperazines; Random Allocation; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2015 |
ICH E14-compatible holter bin method and its equivalence to individual heart rate correction in the assessment of drug-induced QT changes.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Cross-Over Studies; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Long QT Syndrome; Male; Thiazoles | 2014 |
The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Cells, Cultured; Dose-Response Relationship, Drug; Female; Fractals; Heart Conduction System; Heart Rate; Humans; Induced Pluripotent Stem Cells; Long QT Syndrome; Myocytes, Cardiac; Piperidines; Thiazoles; Time Factors; Tosyl Compounds | 2016 |
Electrocardiographic monitoring for QT prolongation in patients treated with ziprasidone--a claims database approach.
Topics: Adult; Antipsychotic Agents; Databases, Factual; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Retrospective Studies; Taiwan; Thiazoles; Young Adult | 2009 |
Torsade de pointes after ziprasidone overdose with coingestants.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Drug Overdose; Female; Humans; Long QT Syndrome; Middle Aged; Piperazines; Thiazoles; Torsades de Pointes | 2010 |
Third degree heart block following intramuscular ziprasidone.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Bradycardia; Cardiopulmonary Resuscitation; Dementia, Vascular; Dose-Response Relationship, Drug; Female; Heart Block; Hospitalization; Humans; Injections, Intramuscular; Long QT Syndrome; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2011 |
What can large simple trials do for psychiatry?
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Death, Sudden, Cardiac; Humans; Long QT Syndrome; Multicenter Studies as Topic; Piperazines; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia; Thiazoles | 2011 |
QT interval duration and dispersion in children and adolescents treated with ziprasidone.
Topics: Adolescent; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Piperazines; Potassium; Thiazoles; Torsades de Pointes | 2011 |
The safety of atypical antipsychotics: does QTc provide all the answers?
Topics: Antipsychotic Agents; Humans; Long QT Syndrome; Piperazines; Thiazoles; Torsades de Pointes | 2011 |
Single-dose ziprasidone associated with QT interval prolongation.
Topics: Antipsychotic Agents; Electrocardiography; Emergency Service, Hospital; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychomotor Agitation; Thiazoles | 2012 |
Question regarding ziprasidone and QTc interval prolongation in the ZODIAC study.
Topics: Adult; Antipsychotic Agents; Female; Humans; Long QT Syndrome; Male; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
QT interval--what is normal? Comment on "single-dose ziprasidone associated with QT interval prolongation".
Topics: Antipsychotic Agents; Humans; Long QT Syndrome; Male; Piperazines; Thiazoles | 2012 |
Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
Topics: Antipsychotic Agents; Dibenzothiepins; Electrocardiography; Female; Haloperidol; Heart Rate; Humans; Isoindoles; Long QT Syndrome; Middle Aged; Schizophrenia; Thiazoles; Water-Electrolyte Imbalance | 2012 |
Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
Topics: Adult; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Drug Overdose; Electrocardiography; Heart Diseases; Humans; Hydrogen-Ion Concentration; Long QT Syndrome; Male; Piperazines; Suicide, Attempted; Thiazoles | 2003 |
Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
Topics: Adolescent; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Consciousness; Depressive Disorder, Major; Drug Overdose; Electrocardiography; Heart Diseases; Humans; Hydrogen-Ion Concentration; Lidocaine; Long QT Syndrome; Male; Piperazines; Suicide, Attempted; Thiazoles | 2003 |
Side effects of ziprasidone.
Topics: Antipsychotic Agents; Female; Humans; Hypokalemia; Long QT Syndrome; Magnesium; Middle Aged; Mood Disorders; Piperazines; Thiazoles; Water-Electrolyte Imbalance | 2003 |
QTc prolongation in multiple drug overdose.
Topics: Adult; Bupropion; Drug Overdose; Fluoxetine; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Thiazoles; Valproic Acid | 2004 |
Ziprasidone for sedation of the agitated ED patient.
Topics: Antipsychotic Agents; Droperidol; Drug Labeling; Emergency Treatment; Humans; Long QT Syndrome; Piperazines; Practice Guidelines as Topic; Psychomotor Agitation; Thiazoles; Torsades de Pointes; United States; United States Food and Drug Administration | 2004 |
No significant QTc interval changes with high-dose ziprasidone: a case series.
Topics: Adult; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Retrospective Studies; Serotonin Antagonists; Thiazoles | 2004 |
[Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
Topics: Acute Disease; Aged; Antipsychotic Agents; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Hallucinations; Humans; Long QT Syndrome; Male; Piperazines; Quetiapine Fumarate; Schizophrenia, Paranoid; Thiazoles | 2004 |
Ziprasidone: first year experience in a hospital setting.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Electrocardiography; Female; Hospitalization; Humans; Inpatients; Length of Stay; Long QT Syndrome; Male; Middle Aged; Mood Disorders; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Arrhythmias, Cardiac; Dementia; Electrocardiography; Female; Haloperidol; Humans; Injections, Intramuscular; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychomotor Agitation; Retrospective Studies; Risk Factors; Thiazoles; Torsades de Pointes | 2005 |
Electrocardiographic changes with ziprasidone.
Topics: Adolescent; Antipsychotic Agents; Child; Data Interpretation, Statistical; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Research Design; Selection Bias; Thiazoles; Tourette Syndrome | 2006 |
QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.
Topics: Adult; Amantadine; Analgesics, Non-Narcotic; Antipsychotic Agents; Drug Overdose; Drug Therapy, Combination; Electrocardiography; Fatal Outcome; Female; Humans; Ibuprofen; Long QT Syndrome; Piperazines; Suicide, Attempted; Thiazoles; Torsades de Pointes | 2007 |
Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
Topics: Adult; Antipsychotic Agents; Bradycardia; Electrocardiography; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Long QT Syndrome; Medication Errors; Piperazines; Thiazoles | 2008 |
Experience with ziprasidone.
Topics: Adolescent; Antipsychotic Agents; Contraindications; Depressive Disorder, Major; Drug Evaluation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Thiazoles | 2002 |
Prolongation of QTc interval and antipsychotics.
Topics: Antipsychotic Agents; Death, Sudden, Cardiac; Drug Administration Schedule; Drug Labeling; Drug Monitoring; Haloperidol; Humans; Long QT Syndrome; Piperazines; Risperidone; Thiazoles | 2002 |